Page 2 - Schulhoff Co News Today

Schulhoff & Co. Inc. lowered its stake in shares of United Parcel Service, Inc. (NYSE:UPS – Free Report) by 5.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 24,328 shares of the transportation company’s stock after selling 1,488 shares during […]

Schulhoff & Co. Inc. reduced its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 0.8% during the third quarter, Holdings Channel.com reports. The firm owned 56,659 shares of the biopharmaceutical company’s stock after selling 456 shares during the quarter. Pfizer accounts for approximately 1.0% of Schulhoff & Co. Inc.’s holdings, making the stock its […]

Schulhoff & Co. Inc. cut its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 0.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 56,659 shares of the biopharmaceutical company’s stock after selling 456 shares during the […]

Schulhoff & Co. Inc. decreased its position in shares of United Parcel Service, Inc. (NYSE:UPS – Free Report) by 5.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 24,328 shares of the transportation company’s stock after selling 1,488 shares during the period. United Parcel Service accounts for […]

SVB Leerink started coverage on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a report issued on Tuesday, Marketbeat.com reports. The firm issued an outperform rating and a $12.00 target price on the stock. A number of other brokerages have also recently weighed in on PYXS. HC Wainwright reissued a buy rating and issued […]

Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has been given a consensus recommendation of “Buy” by the seven ratings firms that are presently covering the company, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock […]

Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has earned an average rating of “Buy” from the seven ratings firms that are covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the […]

StockNews.com assumed coverage on shares of Cedar Fair (NYSE:FUN – Free Report) in a report released on Saturday. The brokerage issued a buy rating on the stock. Several other equities analysts have also recently weighed in on FUN. Morgan Stanley increased their price target on Cedar Fair from $50.00 to $55.00 and gave the company […]

StockNews.com assumed coverage on shares of Cedar Fair (NYSE:FUN – Free Report) in a report released on Friday. The brokerage issued a buy rating on the stock. Several other equities analysts have also weighed in on FUN. Stifel Nicolaus cut their price target on Cedar Fair from $51.00 to $49.00 and set a buy rating […]

StockNews.com initiated coverage on shares of Cedar Fair (NYSE:FUN – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a buy rating on the stock. Several other research firms also recently weighed in on FUN. Stifel Nicolaus decreased their price target on shares of Cedar Fair from $51.00 to $49.00 […]